WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO aims at promoting scientific excellence in fundamental life sciences research and translating scientific achievements in medical, pharmaceutical and veterinary biotechnology applications. 

NEWS

WELBIO launches a 2nd call for projects.

17/02/2012 – WELBIO will launch, on 27 February 2012, a 2nd call for projects in fundamental research in life sciences in domains that may lead to medical, pharmaceutical and/or veterinary biotechnology applications. This call is open to junior scientists (max 12 years post-PHD) as well as to established researchers. The forms and procedures for submission and evaluation will be available on the website starting on 27 February 2012.

 Emile Van Schaftingen (UCL) is the recipient of the 2011-2012 Chaire Francqui.

15/02/2012 – This cycle of conferences will focus on intermediate metabolism in the post-genomic era and will take place at the Facultés Universitaires Notre-Dame de la Paix de Namur.  Read more... 

A new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells.  

19/10/2011 - In a study published in Nature, researchers identify a new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells. The study was lead by Cédric Blanpain, WELBIO investigator at Université Libre de Bruxelles, in collaboration with the groups of Peter Carmeliet (VIB/K.U.Leuven) and Jody J. Haigh (VIB/UGent). The results can have important implications for the prevention and treatment of different epithelial cancers.  Read more...